UniProt ID | CNKR1_HUMAN | |
---|---|---|
UniProt AC | Q969H4 | |
Protein Name | Connector enhancer of kinase suppressor of ras 1 | |
Gene Name | CNKSR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 720 | |
Subcellular Localization |
Cytoplasm. Membrane Peripheral membrane protein. |
|
Protein Description | May function as an adapter protein or regulator of Ras signaling pathways.. | |
Protein Sequence | MEPVETWTPGKVATWLRGLDDSLQDYPFEDWQLPGKNLLQLCPQSLEALAVRSLGHQELILGGVEQLQALSSRLQTENLQSLTEGLLGATHDFQSIVQGCLGDCAKTPIDVLCAAVELLHEADALLFWLSRYLFSHLNDFSACQEIRDLLEELSQVLHEDGPAAEKEGTVLRICSHVAGICHNILVCCPKELLEQKAVLEQVQLDSPLGLEIHTTSNCQHFVSQVDTQVPTDSRLQIQPGDEVVQINEQVVVREERDMVGWPRKNMVRELLREPAGLSLVLKKIPIPETPPQTPPQVLDSPHQRSPSLSLAPLSPRAPSEDVFAFDLSSNPSPGPSPAWTDSASLGPEPLPIPPEPPAILPAGVAGTPGLPESPDKSPVGRKKSKGLATRLSRRRVSCRELGRPDCDGWLLLRKAPGGFMGPRWRRRWFVLKGHTLYWYRQPQDEKAEGLINVSNYSLESGHDQKKKYVFQLTHDVYKPFIFAADTLTDLSMWVRHLITCISKYQSPGRAPPPREEDCYSETEAEDPDDEAGSHSASPSPAQAGSPLHGDTSPAATPTQRSPRTSFGSLTDSSEEALEGMVRGLRQGGVSLLGQPQPLTQEQWRSSFMRRNRDPQLNERVHRVRALQSTLKAKLQELQVLEEVLGDPELTGEKFRQWKEQNRELYSEGLGAWGVAQAEGSSHILTSDSTEQSPHSLPSDPEEHSHLCPLTSESSLRPPDL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MEPVETWTPGKVA --CCCCCCCCCCHHH | 34.57 | 26270265 | |
8 | Phosphorylation | MEPVETWTPGKVATW CCCCCCCCCCHHHHH | 29.59 | 26270265 | |
8 (in isoform 2) | Phosphorylation | - | 29.59 | 27251275 | |
22 | Phosphorylation | WLRGLDDSLQDYPFE HHHCCCCCCCCCCCC | 27.83 | - | |
26 | Phosphorylation | LDDSLQDYPFEDWQL CCCCCCCCCCCCCCC | 9.25 | - | |
278 | Phosphorylation | LREPAGLSLVLKKIP HHCCCCCEEEEECCC | 18.60 | - | |
282 (in isoform 2) | Phosphorylation | - | 40.97 | 24719451 | |
286 (in isoform 2) | Phosphorylation | - | 5.69 | 24719451 | |
289 | Phosphorylation | KKIPIPETPPQTPPQ ECCCCCCCCCCCCCC | 34.61 | 30278072 | |
293 | Phosphorylation | IPETPPQTPPQVLDS CCCCCCCCCCCCCCC | 42.59 | 30278072 | |
293 (in isoform 2) | Phosphorylation | - | 42.59 | 24719451 | |
298 (in isoform 2) | Phosphorylation | - | 4.55 | 24719451 | |
300 | Phosphorylation | TPPQVLDSPHQRSPS CCCCCCCCCCCCCCC | 21.81 | 30278072 | |
300 (in isoform 2) | Phosphorylation | - | 21.81 | 24719451 | |
305 | Phosphorylation | LDSPHQRSPSLSLAP CCCCCCCCCCCCCCC | 16.57 | 25159151 | |
307 (in isoform 2) | Phosphorylation | - | 31.66 | 24719451 | |
307 | Phosphorylation | SPHQRSPSLSLAPLS CCCCCCCCCCCCCCC | 31.66 | 19664994 | |
309 | Phosphorylation | HQRSPSLSLAPLSPR CCCCCCCCCCCCCCC | 27.16 | 22167270 | |
314 | Phosphorylation | SLSLAPLSPRAPSED CCCCCCCCCCCCCCC | 15.98 | 19664994 | |
385 (in isoform 2) | Phosphorylation | - | 67.81 | 24719451 | |
389 | Phosphorylation | KKSKGLATRLSRRRV CCHHHHHHHHHHHCC | 36.87 | 27251275 | |
392 | Phosphorylation | KGLATRLSRRRVSCR HHHHHHHHHHCCCHH | 22.05 | 29496963 | |
414 | Acetylation | DGWLLLRKAPGGFMG CCEEEEECCCCCCCC | 59.92 | 412439279 | |
456 | Phosphorylation | GLINVSNYSLESGHD CCEEEECCCCCCCCC | 13.71 | - | |
515 (in isoform 2) | Phosphorylation | - | 65.05 | 27251275 | |
519 | Phosphorylation | PPREEDCYSETEAED CCCHHHCCCCCCCCC | 23.12 | 27251275 | |
520 | Phosphorylation | PREEDCYSETEAEDP CCHHHCCCCCCCCCC | 44.36 | 28348404 | |
522 | Phosphorylation | EEDCYSETEAEDPDD HHHCCCCCCCCCCCC | 34.26 | 28348404 | |
526 (in isoform 2) | Phosphorylation | - | 60.00 | 27251275 | |
533 | Phosphorylation | DPDDEAGSHSASPSP CCCCCCCCCCCCCCH | 22.71 | 27251275 | |
557 (in isoform 2) | Phosphorylation | - | 23.08 | 27251275 | |
558 (in isoform 2) | Phosphorylation | - | 32.06 | 24719451 | |
561 (in isoform 2) | Phosphorylation | - | 14.65 | 27251275 | |
563 (in isoform 2) | Phosphorylation | - | 44.22 | 24719451 | |
564 | Phosphorylation | PTQRSPRTSFGSLTD CCCCCCCCCCCCCCC | 31.62 | 24719451 | |
565 | Phosphorylation | TQRSPRTSFGSLTDS CCCCCCCCCCCCCCC | 28.96 | 25106551 | |
568 | Phosphorylation | SPRTSFGSLTDSSEE CCCCCCCCCCCCCHH | 26.53 | 25106551 | |
570 | Phosphorylation | RTSFGSLTDSSEEAL CCCCCCCCCCCHHHH | 35.22 | 28857561 | |
572 | Phosphorylation | SFGSLTDSSEEALEG CCCCCCCCCHHHHHH | 34.12 | 28348404 | |
573 | Phosphorylation | FGSLTDSSEEALEGM CCCCCCCCHHHHHHH | 42.12 | 24719451 | |
590 | Phosphorylation | GLRQGGVSLLGQPQP HHHHCCCCCCCCCCC | 22.58 | 24043423 | |
599 | Phosphorylation | LGQPQPLTQEQWRSS CCCCCCCCHHHHHHH | 36.42 | 24043423 | |
599 (in isoform 2) | Phosphorylation | - | 36.42 | 24719451 | |
606 | Phosphorylation | TQEQWRSSFMRRNRD CHHHHHHHHHHHCCC | 17.94 | 24719451 | |
665 | Phosphorylation | KEQNRELYSEGLGAW HHHHHHHHHCCCCHH | 10.42 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNKR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNKR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RASF1_HUMAN | RASSF1 | physical | 15075335 | |
STK3_HUMAN | STK3 | physical | 15075335 | |
STK4_HUMAN | STK4 | physical | 15075335 | |
RAF1_HUMAN | RAF1 | physical | 15075335 | |
GNDS_HUMAN | RALGDS | physical | 14749388 | |
CYH4_HUMAN | CYTH4 | physical | 25416956 | |
RHOA_HUMAN | RHOA | physical | 14749388 | |
RHPN1_HUMAN | RHPN1 | physical | 14749388 | |
CYH2_HUMAN | CYTH2 | physical | 28514442 | |
CYH1_HUMAN | CYTH1 | physical | 28514442 | |
CYH3_HUMAN | CYTH3 | physical | 28514442 | |
HAUS5_HUMAN | HAUS5 | physical | 28514442 | |
ASPM_HUMAN | ASPM | physical | 28514442 | |
PHLB3_HUMAN | PHLDB3 | physical | 28514442 | |
TIF1A_HUMAN | TRIM24 | physical | 28514442 | |
BRCA2_HUMAN | BRCA2 | physical | 28514442 | |
TRI33_HUMAN | TRIM33 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307 AND SER-314, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305 AND SER-314, ANDMASS SPECTROMETRY. |